Literature DB >> 17901927

Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.

Andrea Zarkovic1, Stephen Guest.   

Abstract

We describe a case of traumatic endophthalmitis due to Scedosporium apiospermum that was successfully treated with a combination of intravitreal and systemic voriconazole. A high dose of 200 microg was used intravitreally without any apparent complications. A brief overview of voriconazole use for treatment of ocular infections is presented, and a comparison is made with antifungal agents traditionally used in ophathalmology.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17901927     DOI： 10.1007/s10792-007-9095-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.031


  21 in total

Review 1.  Voriconazole: in the treatment of invasive aspergillosis.

Authors:  Richard B R Muijsers; Karen L Goa; Lesley J Scott
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.

Authors:  Judy E Kim; Stephen L Perkins; Gerald J Harris
Journal:  Arch Ophthalmol       Date:  2003-05

Review 3.  Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.

Authors:  Jorge Garbino; Adriana Ondrusova; Edoardo Baglivo; Daniel Lew; Kathum Bouchuiguir-Wafa; Peter Rohner; Edoardo Baligvo
Journal:  Scand J Infect Dis       Date:  2002

4.  Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.

Authors:  Michal Kramer; Mordechai R Kramer; Hannah Blau; Jihad Bishara; Ruth Axer-Siegel; Dov Weinberger
Journal:  Ophthalmology       Date:  2006-05-19       Impact factor: 12.079

5.  Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.

Authors:  Eric Nulens; Cathrien Eggink; Antonius J M M Rijs; Pieter Wesseling; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

6.  Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis.

Authors:  Ingrid U Scott; Vanessa Cruz-Villegas; Harry W Flynn; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

7.  Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.

Authors:  Seenu M Hariprasad; William F Mieler; Eric R Holz; Hua Gao; Judy E Kim; Jingduan Chi; Randall A Prince
Journal:  Arch Ophthalmol       Date:  2004-01

Review 8.  New options for the treatment of invasive fungal infections.

Authors:  Zachary A Rubin; Jyoti Somani
Journal:  Semin Oncol       Date:  2004-04       Impact factor: 4.929

Review 9.  Voriconazole -- better chances for patients with invasive mycoses.

Authors:  Mahmoud A Ghannoum; D M Kuhn
Journal:  Eur J Med Res       Date:  2002-05-31       Impact factor: 2.175

Review 10.  In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors:  A Espinel-Ingroff; K Boyle; D J Sheehan
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785
View more
  1 in total

1.  Scedosporium apiospermum endopthalmitis treated early with intravitreous voriconazole results in recovery of vision.

Authors:  Monika Paroder Belenitsky; Catherine Liu; Irena Tsui
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.